The Centers for Disease Control and Prevention today issued updated recommendations for managing and reporting Shigella infections that were treated with ciprofloxacin or azithromycin and resulted in possible clinical treatment failure. “If treatment failure is suspected, clinicians should consider consulting an infectious disease specialist to identify best treatment options, and submit a stool specimen for antimicrobial susceptibility testing,” CDC said. “Clinicians should monitor patients carefully and report cases of possible clinical treatment failure to CDC.” Shigella bacteria can cause Shigellosis, a diarrheal disease that should be reported to local health departments. 

Related News Articles

Headline
A total of 2,291 patients have been hospitalized for vaping-associated lung injuries in the states, Puerto Rico and U.S. Virgin Islands, and 48 people have…
Headline
Achieving the U.S. goal of reducing new HIV infections by 90% over 10 years will require accelerated efforts to diagnose, treat and prevent HIV, according to a…
Headline
A new Centers for Disease Control and Prevention study published today in JAMA Pediatrics reveals that nearly one in five adolescents aged 12-18 years,…
Headline
The Centers for Disease Control and Prevention today released updated guidance to help health care providers diagnose and treat patients with vaping-…
Headline
The Centers for Disease Control and Prevention yesterday updated the number of people with confirmed or probable lung injuries associated with electronic…
Headline
A record low 13.7% of U.S. adults smoked cigarettes in 2018, down from 14% in 2017, according to a report released yesterday by the Centers for Disease…